TAT for Enzyme/Protein Delivery to Restore or Destroy Cell Activity in Human Diseases
Open Access
Abstract
Much effort has been dedicated in the recent decades to find novel protein/enzyme-based therapies for human diseases, the major challenge of such therapies being the intracellular delivery and reaching sub-cellular organelles. One promising approach is the use of cell-penetrating peptides (CPPs) for delivering enzymes/proteins into cells. In this review, we describe the potential therapeutic usages of CPPs (mainly trans-activator of transcription protein, TAT) in enabling the uptake of biologically active proteins/enzymes needed in cases of protein/enzyme deficiency, concentrating on mitochondrial diseases and on the import of enzymes or peptides in order to destroy pathogenic cells, focusing on cancer cells.Keywords
This publication has 126 references indexed in Scilit:
- Cell Penetrating Peptides in the Delivery of BiopharmaceuticalsBiomolecules, 2012
- A TAT–Frataxin fusion protein increases lifespan and cardiac function in a conditional Friedreich's ataxia mouse modelHuman Molecular Genetics, 2011
- Backbone rigidity and static presentation of guanidinium groups increases cellular uptake of arginine-rich cell-penetrating peptidesNature Communications, 2011
- Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivoNucleic Acids Research, 2011
- Improvement of different vaccine delivery systems for cancer therapyMolecular Cancer, 2011
- Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndromeEuropean Heart Journal, 2010
- In vivocharacterization of activatable cell penetrating peptides for targeting protease activity in cancerIntegrative Biology, 2009
- Twenty years of cell‐penetrating peptides: from molecular mechanisms to therapeuticsBritish Journal of Pharmacology, 2009
- Delivery of Macromolecules Using Arginine-Rich Cell-Penetrating Peptides: Ways to Overcome Endosomal EntrapmentThe AAPS Journal, 2009
- A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary MedicineAnnual Review of Genetics, 2005